| Value | ₹105.5 Cr |
|---|
BSE filing, NSE: JUBLPHARMA. Summary written from the filing by ALFA Finder's alert engine.
Jubilant Pharmova Ltd: key numbers
- Share price
- ₹923.80
- Market cap
- ₹14,714 Cr
- Revenue (annual)
- ₹8,280 Cr
- Net profit (annual)
- ₹398.5 Cr
- P/E (TTM)
- 41.8×Sector 45.9×
- Promoter holding
- 47.68%+0.00% QoQ
- FII holding
- 15.37%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Jubilant Pharmova Ltd
All →Jubilant Pharmova Board Meeting Date
Jubilant Pharmova has scheduled a board meeting for November 13, 2026 to consider unaudited standalone and consolidated results for the quarter and half year ended September 30, 2026. The filing is a Regulation 29 advance intimation only.
Jubilant Pharmova Annual General Meeting
Jubilant Pharmova Ltd has issued a Postal Ballot Notice seeking shareholder approval for the private placement issuance of Non-Convertible Debentures.
Jubilant Pharmova Credit Rating
Jubilant Pharmova received a credit rating of IND AA+/Stable from India Ratings and Research for its proposed Non-Convertible Debentures worth ₹1,400 Crore.
- Value
- ₹1,400 Cr
Jubilant Pharmova Other Announcement
Jubilant Pharmova Ltd filed its quarterly shareholding pattern for the period ended September 30, 2026, as required under SEBI regulations.
Jubilant Pharmova Credit Rating
Jubilant Pharmova received an [ICRA]AA+ (Stable) rating from ICRA for its proposed non-convertible debentures. This confirms the credit assessment for the upcoming debt instrument.
Jubilant Pharmova Debt & Borrowing: ₹800 Cr
Jubilant Pharmova board approved NCD issuance up to ₹800 crore on private placement basis. Postal ballot also sought for NCD authorization up to ₹2,500 crore.
- Value
- ₹800.0 Cr
- Execution
- Upto five years from the Deemed Date of Allotment
Other legal & regulatory announcements
All →Bharti Airtel Legal & Regulatory
Bharti Airtel received a TRAI order imposing a financial disincentive of ₹54.06 lakh for CCPR non-compliance. The company disagrees with the order and plans to seek reversal.
- Value
- ₹0.54 Cr
YES Bank Legal & Regulatory
Yes Bank's AT-1 bonds remain unrestored after the Supreme Court's 15 October 2026 judgment. Axis Trustee threatens contempt proceedings unless the bank acts within three days.
Net Avenue Technologies Legal & Regulatory
Net Avenue Technologies disclosed that the GST department has appealed against an order dropping a show cause notice proceeding. The company will update investors upon further communication.
Fine Organic Industries Legal & Regulatory
Fine Organic's offices and manufacturing units faced a Maharashtra GST inspection on October 30, 2026. The company says operations are unaffected and it expects no material impact.
Tilaknagar Industries Legal & Regulatory
Tilaknagar Industries disclosed a DRI search under Section 105 of the Customs Act on October 22, 2026. The search is part of an industry-wide HSN review, and the company reports no impact as of now.
Rallis India Legal & Regulatory
Rallis India received an income tax give-effect order dropping a Rs.408 crore demand for AY 2022-23. The company will get a refund of Rs.8.31 crore including Rs.1.79 crore interest.
- Value
- ₹8.31 Cr